Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo

ConditionsMeconium-stained Amniotic Fluid Chorioamnionitis

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorWestern Galilee Hospital-Nahariya

About this trial

Our randomized controlled double blind clinical trail aims to compare maternal and neonatal infectious morbidity between women with meconium-stained amniotic fluid treated with zinacef vs. placebo.

Eligibility criteria

Qualifiers

singleton pregnancy at term

meconium-stained amniotic fluid

Disqualifiers

Intrauterine fetal death

GBS carriers

zinacef allergy

antibiotic treatment for other indication

Trial design

Treatments tested in this trial

zinacef tretment
Placebo

Treatment groups

182 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Western Galilee Hospital-Nahariya

Lead sponsor

Source ClinicalTrials.gov